Overall, the evidence indicates that Nrf2 activity is more often elevated in hippocampus and temporal cortex in Alzheimer’s disease, whereas Nrf2 activity in frontal cortex is more variable. Here, NFE2L2 is linked to early-onset autosomal dominant Alzheimer disease.